BlackRock’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BlackRock's LLY Position: Q2 2026 in Review
BlackRock increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $1.18B and bringing the position to 67,540,400 shares worth $81B. The position accounts for 1.2% of the portfolio, ranked #12.
BlackRock first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- BlackRock held 67,540,400 shares of Eli Lilly worth $81B as of Q2 2026.
- BlackRock bought 1,159,558 Eli Lilly shares in Q2 2026, an estimated $1.18B.
- Eli Lilly made up 1.2% of BlackRock's portfolio in Q2 2026, its #12 holding.
- BlackRock first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.